Sign up Australia
Proactive Investors - Run By Investors For Investors

De.mem to enter lucrative Australian water treatment market via acquisition

The acquisition will strengthen the Singapore company’s position in the Asia Pacific region.
Water treatment plant
The consideration for the transaction includes $1.5 million in cash

De Mem Ltd (ASX:DEM) is expanding into Australia by acquiring Akwa-Worx, a Queensland based provider of water and waste water treatment systems.

The acquisition will strengthen the Singapore-based water treatment company De.mem’s position in the Asia Pacific region and provides an opportunity for growth in the mining and industrial sectors.

Akwa-Worx currently supplies products for de-centralised industrial and municipal water and waste water treatment in Australia.

The company’s product lines include Ultra Filtration (UF) Reverse Osmosis (RO) based systems, Membrane Bioreactors (MBRs), bioreactors and chemical dosing systems.

The systems are typically delivered as packaged or modular solutions for de-centralised applications.

Akwa-Worx’s clients include a number of leading corporations from the Australian mining sector and its subsidiary’s ongoing long-term maintenance contracts provide a stable recurring revenue component.

The company’s revenues for the 12 months ended 30 June 2017 were circa $7 million including more than $2 million derived from long-term operations and maintenance contracts.

Akwa-Worx’s normalised EBITDA for FY17 was circa $800,000.

The acquisition will result in the combination of De.mem’s innovative membrane technologies with Akwa-Worx’s established position and proven product offering in Australia.

The consideration for the transaction is $1.5 million in cash and $460,000 in De-mem shares, plus milestone shares and cash on crossing pre-set revenue targets for the next two years.

View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

Throne of Glass
October 23 2018
Rowling, Rowling, Rowling ... keep those titles rolling. Mind you, it's not all about Ms Rowling; Sarah J Maas title revenues grew 47% in the first half of the financial year and dieters are gorging on Tom Kerridge's books
Apollo 11
February 22 2018
Immersive VR, a technology company focused on the education space, was the first company Sure backed
September 20 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use